Naffouje, R.; Grover, P.; Yu, H.; Sendilnathan, A.; Wolfe, K.; Majd, N.; Smith, E.P.; Takeuchi, K.; Senda, T.; Kofuji, S.;
et al. Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story. Cancers 2019, 11, 1346.
https://doi.org/10.3390/cancers11091346
AMA Style
Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N, Smith EP, Takeuchi K, Senda T, Kofuji S,
et al. Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story. Cancers. 2019; 11(9):1346.
https://doi.org/10.3390/cancers11091346
Chicago/Turabian Style
Naffouje, Rand, Punita Grover, Hongyang Yu, Arun Sendilnathan, Kara Wolfe, Nazanin Majd, Eric P. Smith, Koh Takeuchi, Toshiya Senda, Satoshi Kofuji,
and et al. 2019. "Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story" Cancers 11, no. 9: 1346.
https://doi.org/10.3390/cancers11091346
APA Style
Naffouje, R., Grover, P., Yu, H., Sendilnathan, A., Wolfe, K., Majd, N., Smith, E. P., Takeuchi, K., Senda, T., Kofuji, S., & Sasaki, A. T.
(2019). Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story. Cancers, 11(9), 1346.
https://doi.org/10.3390/cancers11091346